Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Maps Out Potential 510(k) Reforms In Long-Awaited Report

This article was originally published in The Gray Sheet

Executive Summary

FDA released its highly anticipated proposals for reforming the 510(k) program last week, and industry reps acknowledged that many of the individual recommendations could benefit companies
Advertisement

Related Content

FDA 510(k) Reform Plan Yields Mixed Readings
FDA 510(k) Reform Plan Yields Mixed Readings
FDA Kicks Off 510(k) Reform Plan, Punts Some Decisions To IOM
510(k) Reform Debate: Class IIb Or Not To Be?
Hamburg: FDA Aims To Issue 510(k) Reform Plan By Year-End
Training Recommendations In 510(k) Report
Regulatory News In Brief
510(k) Reform Does Not Mean Major Increase In Clinical Data Demands - FDA
Shuren's Center: FDA Device Chief Discusses Long Road To 510(k) Reform
Medical Device User Fee Negotiations: Here We Go Again

Topics

Advertisement
UsernamePublicRestriction

Register

MT029223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel